These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15274674)

  • 21. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials.
    Wang WH; Huang JQ; Zheng GF; Xia HH; Wong WM; Liu XG; Karlberg J; Wong BC
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):178-85; quiz 140. PubMed ID: 17174612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
    Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
    Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.
    Bolling-Sternevald E; Lauritsen K; Aalykke C; Havelund T; Knudsen T; Unge P; Ekström P; Jaup B; Norrby A; Stubberöd A; Melén K; Carlsson R; Jerndal P; Junghard O; Glise H
    Scand J Gastroenterol; 2002 Dec; 37(12):1395-402. PubMed ID: 12523588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The placebo response in functional dyspepsia--reanalysis of trial data.
    Enck P; Vinson B; Malfertheiner P; Zipfel S; Klosterhalfen S
    Neurogastroenterol Motil; 2009 Apr; 21(4):370-7. PubMed ID: 19210629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.
    Miwa H; Nagahara A; Tominaga K; Yokoyama T; Sawada Y; Inoue K; Ashida K; Fukuchi T; Hojo M; Yamashita H; Tomita T; Hori K; Oshima T
    Am J Gastroenterol; 2009 Nov; 104(11):2779-87. PubMed ID: 19638966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The efficacy of a combination herbal medicine in the treatment of functional dyspepsia. Meta-analysis of randomized double-blind studies on the basis of a valid gastrointestinal symptom profile].
    Gundermann KJ; Godehardt E; Ulbrich M
    MMW Fortschr Med; 2004 Aug; 146 Suppl 2():71-6. PubMed ID: 16739362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypersensitivity for capsaicin in patients with functional dyspepsia.
    Hammer J; Führer M; Pipal L; Matiasek J
    Neurogastroenterol Motil; 2008 Feb; 20(2):125-33. PubMed ID: 17931342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.
    Ye BD; Cheon JH; Choi KD; Kim SG; Kim JS; Jung HC; Song IS
    Aliment Pharmacol Ther; 2006 Sep; 24(5):837-43. PubMed ID: 16918888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study.
    von Arnim U; Peitz U; Vinson B; Gundermann KJ; Malfertheiner P
    Am J Gastroenterol; 2007 Jun; 102(6):1268-75. PubMed ID: 17531013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
    Vakil N; Talley NJ; Stolte M; Sundin M; Junghard O; Bolling-Sternevald E
    Aliment Pharmacol Ther; 2006 Jul; 24(1):55-63. PubMed ID: 16803603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea.
    Lee KJ; Demarchi B; Demedts I; Sifrim D; Raeymaekers P; Tack J
    Am J Gastroenterol; 2004 Sep; 99(9):1765-73. PubMed ID: 15330916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse.
    Reimer C; Bytzer P
    Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1182-8. PubMed ID: 20664352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials.
    Vakil N; Laine L; Talley NJ; Zakko SF; Tack J; Chey WD; Kralstein J; Earnest DL; Ligozio G; Cohard-Radice M
    Am J Gastroenterol; 2008 Aug; 103(8):1906-19. PubMed ID: 18616658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.